Cumberland Pharmaceuticals (CPIX) Tops Q3 EPS by 6c
More News related to CPIX
- Morgan Joseph Reiterates a 'Buy' on Cumberland Pharmaceuticals (CPIX)
- Morning Movers 11/10: UPG, CYD, PCLN, FLL, BZH Higher; RHIE, OPXT, PRKR, PIKE, MBI, SDTH Lower
- Cumberland Pharmaceuticals (CPIX) Tops Q3 EPS by 6c
- Cumberland Pharmaceuticals Reports 58% Increase in Net Revenue With Third Quarter 2009 Financial Results
- Cumberland Pharmaceuticals to Present at Lazard Healthcare Conference in New York on November 17, 2009
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) reports Q3 EPS of $0.07 vs. consensus of $0.01. Revenues were $13.6 million vs. $11.08 million consensus.
Excluding the non-recurring payroll tax expense, net income for the three months ended September 30, 2009, would have increased 54% to $1.9 million, or $0.10 per diluted share.
[SM]
Related Categories
EarningsStocks Mentioned
+0.82Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
